家 » 全て » 株価予想 » ARS Pharmaceuticals Inc. Common Stock 予報

ARS Pharmaceuticals Inc. Common Stock 予報: 明日, 週, 月, 5年

更新されました: April 22 · 2026 at 07:03 UTC

From

▼ -4.16%Market Cap $778.49M · Technical analysis Bearish · Focus area Price + volatility

予測の概要

時間枠	予想価格	過去	歴史的	洞察力
明日	$7.95 ▲ +1.41%	昨日	$7.79 ▼ -0.59%	Tomorrow's ARS Pharmaceuticals Inc. Common Stock (SPRY) setup is anchored to $7.84 and targets $7.95 (+1.41%). The near-term read is upside; watch $8.08 / $7.60 because daily realized volatility is about 7.29%.
Tomorrow's ARS Pharmaceuticals Inc. Common Stock (SPRY) setup is anchored to $7.84 and targets $7.95 (+1.41%). The near-term read is upside; watch $8.08 / $7.60 because daily realized volatility is about 7.29%.
週	$8.18 ▲ +4.40%	先週	$7.70 ▼ -1.85%	The 7-day ARS Pharmaceuticals Inc. Common Stock model moves from $7.70 to $8.18 (+4.40%). It gives upside momentum context for this stock, so breaks around $8.08 / $7.60 matter more than a single tick.
The 7-day ARS Pharmaceuticals Inc. Common Stock model moves from $7.70 to $8.18 (+4.40%). It gives upside momentum context for this stock, so breaks around $8.08 / $7.60 matter more than a single tick.
月	$8.57 ▲ +9.37%	先月	$7.53 ▼ -3.94%	The 1-month ARS Pharmaceuticals Inc. Common Stock target is $8.57 (+9.37%), compared with the live reference near $7.84. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month ARS Pharmaceuticals Inc. Common Stock target is $8.57 (+9.37%), compared with the live reference near $7.84. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
年	$9.16 ▲ +16.82%	去年	$7.29 ▼ -7.07%	The 1-year ARS Pharmaceuticals Inc. Common Stock scenario points to $9.16 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year ARS Pharmaceuticals Inc. Common Stock scenario points to $9.16 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5年	$10.53 ▲ +34.29%	5年前	$6.71 ▼ -14.40%	The 5-year ARS Pharmaceuticals Inc. Common Stock view is $10.53 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year ARS Pharmaceuticals Inc. Common Stock view is $10.53 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

明日$7.95▲ +1.41%

昨日$7.79▼ -0.59%

Tomorrow's ARS Pharmaceuticals Inc. Common Stock (SPRY) setup is anchored to $7.84 and targets $7.95 (+1.41%). The near-term read is upside; watch $8.08 / $7.60 because daily realized volatility is about 7.29%.

週$8.18▲ +4.40%

先週$7.70▼ -1.85%

The 7-day ARS Pharmaceuticals Inc. Common Stock model moves from $7.70 to $8.18 (+4.40%). It gives upside momentum context for this stock, so breaks around $8.08 / $7.60 matter more than a single tick.

月$8.57▲ +9.37%

先月$7.53▼ -3.94%

The 1-month ARS Pharmaceuticals Inc. Common Stock target is $8.57 (+9.37%), compared with the live reference near $7.84. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

年$9.16▲ +16.82%

去年$7.29▼ -7.07%

The 1-year ARS Pharmaceuticals Inc. Common Stock scenario points to $9.16 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5年$10.53▲ +34.29%

5年前$6.71▼ -14.40%

The 5-year ARS Pharmaceuticals Inc. Common Stock view is $10.53 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

価格表

歴史的予報強気弱気

テクニカル分析

Neutral

強気

中性

弱気

主要な指標

インジケータ	価値	信号
Price	$7.84	Mid
Daily Change	-4.16%	Below
Volatility Cap	20.0%	Mid
Confidence	66%	Above
Data Source	nasdaq-screener	Mid

過去のデータ

Current$7.84

Daily Change-4.16%

Market Cap$778.49M

Sourcenasdaq-screener

Current	$7.84	Daily Change	-4.16%
Market Cap	$778.49M	Source	nasdaq-screener

サポートとレジスタンスのレベル

$7.60Support 1

$7.84現在

$8.08Resistance 1

shield

Support and resistance are estimated from the trusted current price until deeper historical data is available.

価格マイルストーン

主要なレベルと歴史的背景

Current$7.84Live reference price

Used as the anchor for generated forecast calculations.

Next Month$8.57Model projection+9.37%

Directional scenario based on capped drift.

予測精度

私たちのモデルのパフォーマンス

66%

指向性

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

当社のアルゴリズムは、最新の価格動向、ボラティリティ体制、指標シグナルを使用して毎週再調整されます。精度は時間枠によって異なります。短期的な勢いは長期的な予測よりも信頼性が高くなります。

Short term

66%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

投資シナリオ

今日 $1,000 を SPRY に投資した場合

Bullish Scenario

$8.23

+5.00% from current

目標価格$8.23

シナリオUpside momentum

確率58%

Base Scenario

$8.57

+9.37%

目標価格$8.57

シナリオCapped drift

確率66%

Bearish Scenario

$7.45

-5.00% from current

目標価格$7.45

シナリオVolatility drawdown

確率34%

基礎: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

予測要因

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 70/100

24H drift+1.41%

7D drift+4.40%

30D drift+9.37%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 67/100

1M outlook+9.37%

1Y outlook+16.82%

5Y outlook+34.29%

よくある質問

Q What is the ARS Pharmaceuticals Inc. Common Stock (SPRY) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), ARS Pharmaceuticals Inc. Common Stock is projected near $7.95 versus the current reference around $7.84. That implies a modeled move of +1.41% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for SPRY?

The weekly ARS Pharmaceuticals Inc. Common Stock model points to $8.18, which maps to an expected drift of +4.40% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the ARS Pharmaceuticals Inc. Common Stock 1-month and 1-year targets?

The ARS Pharmaceuticals Inc. Common Stock 1-month target is $8.57 (+9.37%), while the 1-year target is $9.16 (+16.82%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the ARS Pharmaceuticals Inc. Common Stock 5-year scenario differ from short-term rows?

The ARS Pharmaceuticals Inc. Common Stock long-horizon scenario sits near $10.53 with a modeled change of +34.29%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are SPRY support and resistance zones right now?

For ARS Pharmaceuticals Inc. Common Stock, nearest resistance is around $7.60, while nearest support is around $8.08. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the ARS Pharmaceuticals Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.